1 year return (CAGR)
-94.49%
Marinus Pharmaceuticals Inc Exchange (NASDAQ, USD)
MRNS
-
0.00 (0.00%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-62.46%
5 year return (CAGR)
-42.25%
10 year return (CAGR)
-35.47%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
30.37M
Price/Sales
0.97
Ent value
118.55M
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-6.04%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
No data
Stock price data
| Open | 0.55 |
| Daily high | 0.55 |
| Daily low | 0.55 |
| Daily Volume | 0K |
| 1y analyst estimate | 1.07 |
| Beta | 1.26 |
| EPS (TTM) | -2.45 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| MRNS | S&P500 | |
| Current price drop from All-time high | -99.29% | -0.73% |
| Highest price drop | -99.70% | -56.47% |
| Date of highest drop | 23 Dec 2024 | 9 Mar 2009 |
| Avg drop from high | -77.96% | -10.68% |
| Avg time to new high | 139 days | 12 days |
| Max time to new high | 2396 days | 1805 days |
News
No items found